As of 2025-07-02, the Relative Valuation of Olema Pharmaceuticals Inc (OLMA) is (39.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.37 USD, the upside of Olema Pharmaceuticals Inc based on Relative Valuation is -1008.5%.
The range of the Relative Valuation is (25.06) - (49.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 26.3x | 19.6x |
| Forward P/E multiples | 13.3x - 31.9x | 22.6x |
| Fair Price | (25.06) - (49.55) | (39.70) |
| Upside | -673.3% - -1233.8% | -1008.5% |
| Date | P/E |
| 2025-06-30 | -2.26 |
| 2025-06-27 | -2.45 |
| 2025-06-26 | -2.42 |
| 2025-06-25 | -2.52 |
| 2025-06-24 | -2.49 |
| 2025-06-23 | -2.22 |
| 2025-06-20 | -2.19 |
| 2025-06-18 | -2.18 |
| 2025-06-17 | -2.13 |
| 2025-06-16 | -2.22 |
| 2025-06-13 | -2.21 |
| 2025-06-12 | -2.16 |
| 2025-06-11 | -2.17 |
| 2025-06-10 | -2.23 |
| 2025-06-09 | -2.33 |
| 2025-06-06 | -2.37 |
| 2025-06-05 | -2.23 |
| 2025-06-04 | -2.24 |
| 2025-06-03 | -2.15 |
| 2025-06-02 | -2.32 |
| 2025-05-30 | -2.80 |
| 2025-05-29 | -2.81 |
| 2025-05-28 | -2.63 |
| 2025-05-27 | -2.73 |
| 2025-05-23 | -2.68 |
| 2025-05-22 | -2.74 |
| 2025-05-21 | -2.66 |
| 2025-05-20 | -2.70 |
| 2025-05-19 | -2.55 |
| 2025-05-16 | -2.50 |
| 2025-05-15 | -2.49 |
| 2025-05-14 | -2.39 |
| 2025-05-13 | -2.48 |
| 2025-05-12 | -2.53 |
| 2025-05-09 | -2.44 |
| 2025-05-08 | -2.48 |
| 2025-05-07 | -2.46 |
| 2025-05-06 | -2.44 |
| 2025-05-05 | -2.95 |
| 2025-05-02 | -2.98 |
| 2025-05-01 | -2.81 |
| 2025-04-30 | -2.74 |
| 2025-04-29 | -2.68 |
| 2025-04-28 | -2.60 |
| 2025-04-25 | -2.61 |
| 2025-04-24 | -2.71 |
| 2025-04-23 | -2.66 |
| 2025-04-22 | -2.63 |
| 2025-04-21 | -2.52 |
| 2025-04-17 | -2.35 |